Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia
Clinical trial NCT04720534 · COMPLETED
Trial details
- NCT number
- NCT04720534
- Sponsor
- Arrowhead Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-31
- Primary completion
- 2023-03-09
- Enrollment
- 229
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.